Sahebi, F., & Schönland, S. (2018). Incidence of second primary malignancies after autologous transplantation for multiple myeloma in the era of novel agents. Biology of blood and marrow transplantation, 24(5), . https://doi.org/10.1016/j.bbmt.2018.01.006
Chicago Style (17th ed.) CitationSahebi, Firoozeh, and Stefan Schönland. "Incidence of Second Primary Malignancies After Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents." Biology of Blood and Marrow Transplantation 24, no. 5 (2018). https://doi.org/10.1016/j.bbmt.2018.01.006.
MLA (9th ed.) CitationSahebi, Firoozeh, and Stefan Schönland. "Incidence of Second Primary Malignancies After Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents." Biology of Blood and Marrow Transplantation, vol. 24, no. 5, 2018, https://doi.org/10.1016/j.bbmt.2018.01.006.